Vivimed Divisions

table of products

Vivimed has offices in Hyderabad, India, with five different functional manufacturing centres in proximity to the central office hub. Vivimed has a new state-of-the-art R&D facility close to the central office, and parallel R&D facilities in the UK, which also incorporates the European office for finance, marketing and administration, within this UK facility is the Company's dedicated REACH compliance unit, a sales and distribution hub in north-eastern USA and a representatives office in Guangzhou, China completes the division profile.

Vivimed Manufacturing Units

Bidar - Anti-microbials, preservatives and sunscreen actives

Bonthapally - Home and Personal Care actives production

Jeedimetla - Capsule, tablet, liquid oral and ointment formulations

Haridwar - small volume parenterals sterile products (eye, ear and nasal drop formulations)

Kashipur - Capsule, tablet, liquid oral and ointment formulations

Alathur - USA FDA approved SOD facility

Klar Sehen - Opthalmic & Pharma Products

Alathur

In August 2013, as part of its global business strategy to complete its presence across the entire health care value chain, Vivimed completed the acquisition of a US FDA approved 1.2 billion SOD per annum manufacturing facility at Alathur near Chennai, Tamilnadu. This facility earlier belonged to the US pharma MNC Actavis (Watson) and has received US FDA approval 4 times in April 2007, April 2009, Oct 2011 and most recently in Sep 2013. The plant manufacturing capacity can be expanded to 5 billion SOD per annum. This eliminates 3 to 4 years of lead time to build a green field project of this quality and getting the regulatory approvals.

This strategic acquisition gives Vivimed immediate access to regulated markets such as US and European union. US is the largest generic market in the world. This also enables Vivimed to complete the health vare value chain by providing forward integration synergies for Vivimed’s existing API business.

With the acquisition of the Alathur facility and Finoso, Vivimed will now develop its own formulation dossiers, DMFs and ANDAs and start building a filing pipeline with the Alathur facility as the manufacturing site.

Vivimed Pharma

Starting in the 90s, the Pharma Division of Vivimed is today seen as a preferred partner by large global players in the areas of collaborative research, joint exploration of new markets and as an efficient supply chain partner who can leverage globally benchmarked plants.

The Specialty Pharma division of Vivimed is a merged entity of VVS Pharma and Creative Healthcare. The Specialty Pharma Division has its inherent strengths in drug delivery ad drug discovery. The division is focused on providing cures in oncology space, arthritis, syndrome X, macular degeneration, psoriasis and stress.

Vivimed Labs is certified

ISO9001:2008, ISO14001:2004, OHAS 18001:2007 & SA 8000:2008 via TUV Nord.

These certifications cover quality, environment, occupational health & safety and social accountability management systems for the scope:

Manufacture and supply of speciality chemicals and active pharmaceutical ingredients.

ISO document [PDF]

Memberships & Associations

Vivimed Product Search

Please enable JavaScript

Vivimed Labs Latest News

Visit us at PCHi – Shanghai – Stand P46

Monday, February 10th, 2014

Virtual Hair Care Ingredients Event

Monday, September 16th, 2013

On September 18th 2013 Vivimed will be taking part in … continue reading…

Vivimed are Exhibiting at HPCi – Mumbai.

Wednesday, February 27th, 2013

Vivimed Labs Ltd are exhibiting at this year HPCi held … continue reading…

Convention On Colorants 2013

Monday, February 25th, 2013

Andy Towns (Research Manager) gave an invited lecture on photochromic … continue reading…

Mr.Santosh Varalwar, MD and CEO, Vivimed Labs nominated by Ernst & Young Entrepreneur-Of-The-Year-India-Awards 2012

Thursday, February 21st, 2013

Ernst & Young, the leading professional services firm, today announced … continue reading…

Privacy & Cookies